Literature DB >> 11386628

Choice-matching preference reversals in health outcome assessments.

W Sumner1, R F Nease.   

Abstract

BACKGROUND: Health outcome utility assessments generally assume procedural invariance. Preference reversals violating procedural invariance occur in economic scenarios when the assessment process shifts from a choice to a fill-in-the-blank task.
PURPOSE: To determine if similar reversals occur in utility assessments.
METHODS: One hundred thirty-six volunteer subjects completed 6 preference assessments of 4 personal health scenarios. Patients responded to otherwise identical tasks using either choice or fill-in-the-blank processes in a randomized crossover design. The authors determined the percentage of subjects preferring, or inferred to prefer, a given choice.
RESULTS: Preference reversals occurred in all assessment scenarios.
CONCLUSIONS: These preference reversals are a potential source of confusion for utility assessment and informed consent. They could be manipulated to achieve ends other than the best interest of patients. Anchoring or the prominence hypothesis may explain these findings.

Entities:  

Mesh:

Year:  2001        PMID: 11386628     DOI: 10.1177/0272989X0102100306

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  3 in total

1.  Evidence for the rapid construction of preference during utility assessments.

Authors:  Jonathan Bennett; Robert F Nease; Walton Sumner
Journal:  Proc AMIA Symp       Date:  2002

2.  Influence of elicitation procedure and phrasing on health state valuations in experience-based time trade-off tasks among diabetes patients in China.

Authors:  Shuang Hao; Emelie Heintz; Gert Helgesson; Sophie Langenskiöld; Jiaying Chen; Kristina Burström
Journal:  Qual Life Res       Date:  2019-09-12       Impact factor: 4.147

3.  Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach.

Authors:  Juan M Ramos-Goñi; Jose L Pinto-Prades; Mark Oppe; Juan M Cabasés; Pedro Serrano-Aguilar; Oliver Rivero-Arias
Journal:  Med Care       Date:  2017-07       Impact factor: 2.983

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.